ENT & Allergy Practices Attract Private Equity
JD Supra: Mergers
JULY 19, 2023
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. By: FOCUS Investment Banking One area receiving interest is the ear, nose, and throat (ENT) and allergy field.
Let's personalize your content